BioCentury
ARTICLE | Financial News

Clarus adds former Genentech CEO Ian Clark

September 12, 2017 12:13 AM UTC

Life sciences investment firm Clarus named Ian Clark operating partner on Monday. He was CEO of the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY) and head of Roche's North American commercial operations. In December, Genentech said Clark was retiring. Clark currently serves on several boards, including Kite Pharma Inc. (NASDAQ:KITE), which Gilead Sciences Inc. (NASDAQ:GILD) is acquiring (see BioCentury Extra, Dec. 14, 2016).

Clark was named CEO of Genentech in 2009 (see BioCentury Extra, Sept. 8, 2009). ...